ELI LILLY & Co — Director's Dealing 2024

Feb 14, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-12

Reporting Person: Norton Johna (EVP, Global Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-12	Common Stock	A	1668	$737.26	Acquired	32484	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-12	Restricted Stock Unit	$	A	1308	Acquired	2025-02-01	Common Stock (1308)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	402	Indirect
Common Stock	1769	Indirect
Common Stock	128	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.